Winter 2002

The Industry-University Cooperative Research Program (IUCRP) reorganizes, creating one administrative base for UC Discovery Grants

Fall 2002

The IUCRP begins accepting Major Program Grants(MPGs) for UC Discovery Grants.

Summer 2002

The UC Discovery Grant brand name is adopted, and sector names are retired (BioSTAR, CoRe, DiMI, SMART, LS:IT).

January 2002

The IUCRP begins accepting multi-field, interdisciplinary research proposals.

May 2000

The IUCRP unveils a more sophisticated, new online proposal system, allowing Principal Investigators and Private Sponsors to submit research proposals online.

1999 - 2000

The State of California increases its investment in the IUCRP to $24.6 million/yr (21.6 million from the state, $3 million from UC). Industry responds enthusiastically with matching funds. Total funding, including private contributions, approach $60 million/yr.

Jan. 1999

The IUCRP expands into the field of Information Technology for Life Sciences. Focus areas include high tech, healthcare, agriculture, and environmental technology challenges.

The IUCRP expands into the field of Communications and Networking. The goal is to support new research on communication systems and components that will enable anywhere, anytime communications.

1998 - 1999

The State of California increases its investment in the IUCRP to $15 million/yr ($12 million from the state, $3 million from UC). Industry responds enthusiastically with matching funds. Total funding, including private contributions, exceeds $30 million/yr.

Feb. 1998

The IUCRP expands into the field of Digital Media.

The IUCRP expands into field of Electronics Manufacturing and New Materials to help advance research and training in electronics manufacturing.

Summer 1996

Under the leadership of President Richard Atkinson, the IUCRP is founded at UC Berkeley as a single-field biotechnology program. Initial base funding is $3 million from UC, and quickly grows to $8 million with a $5 million contribution from the State of California. Applications carry commitments of nearly $8 million in cash from California biotech firms in just 3 months.